TELYF (TelyRx Holdings) Accumulated Depreciation: $-0.19 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TELYF TelyRx Holdings Inc TELYF
12 GF Score
Price $1.88
! 2 Warning Signs
View Full Analysis

What is TelyRx Holdings Accumulated Depreciation?

TelyRx Holdings TELYF +1.62% 12 Accumulated Depreciation is $-0.19 Mil as of Jun. 2026. GuruFocus rates TELYF with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

TelyRx Holdings's quarterly accumulated depreciation increased from Dec. 2025 ($-0.11 Mil) to Mar. 2026 ($-0.15 Mil) and increased from Mar. 2026 ($-0.15 Mil) to Jun. 2026 ($-0.19 Mil).

TelyRx Holdings's annual accumulated depreciation increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($-0.01 Mil) and increased from Dec. 2024 ($-0.01 Mil) to Dec. 2025 ($-0.11 Mil).

TelyRx Holdings Accumulated Depreciation Related Terms

TelyRx Holdings Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings Accumulated Depreciation Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
Accumulated Depreciation
-0.00 -0.01 -0.11

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only 0.00 -0.08 -0.11 -0.15 -0.19
TELYF
12GF Score
TelyRx Holdings Inc TELYF
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-0.19 Mil mean?
TelyRx Holdings (TELYF) has a Accumulated Depreciation of $-0.19 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on TelyRx Holdings and its competitors.
Is TelyRx Holdings' Accumulated Depreciation too high?
TelyRx Holdings' current Accumulated Depreciation is $-0.19 Mil. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Accumulated Depreciation compare to ?
TelyRx Holdings' Accumulated Depreciation of $-0.19 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Healthcare Providers & Services company?
A good Accumulated Depreciation depends on the Healthcare Providers & Services industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on TelyRx Holdings and its competitors. TelyRx Holdings's current Accumulated Depreciation is $-0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TELYF) has a current Accumulated Depreciation of $-0.19 Mil. The current Accumulated Depreciation is $-0.19 Mil. TelyRx Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For TelyRx Holdings (TELYF), the current Accumulated Depreciation is $-0.19 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Comparable Companies
Other Exchanges TELY:Canada
Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TELYF

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price